treatment-resistant depression
Biomind Labs Begins CSE Trading While Pipeline Awaits Funding
Biomind Labs Inc. (CSE: BMND; OTC Pink: BMNDF), a Vancouver-based clinical-stage biopharmaceutical company developing central nervous system therapies, began trading on the Canadian Securities Exchange on August 11 under the symbol BMND. Its common shares were previously listed on Cboe Canada, where they were delisted at the close of trading on August 10. Biomind said…
